- Home
- ATEN vs CDNA Comparison
ATEN vs CDNA Comparison
Compare ATEN & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATEN
- CDNA
- Stock Information
- Founded
- ATEN 2004
- CDNA 1998
- Country
- ATEN United States
- CDNA United States
- Employees
- ATEN 481
- CDNA N/A
- Industry
- ATEN EDP Services
- CDNA Medical Specialities
- Sector
- ATEN Technology
- CDNA Health Care
- Exchange
- ATEN Nasdaq
- CDNA Nasdaq
- Market Cap
- ATEN 1.3B
- CDNA 712.2M
- IPO Year
- ATEN 2014
- CDNA 2014
- Fundamental
- Price
- ATEN $17.67
- CDNA $14.02
- Analyst Decision
- ATEN Strong Buy
- CDNA Buy
- Analyst Count
- ATEN 4
- CDNA 8
- Target Price
- ATEN $21.50
- CDNA $26.86
- AVG Volume (30 Days)
- ATEN 621.5K
- CDNA 1.4M
- Earning Date
- ATEN 11-06-2025
- CDNA 11-03-2025
- Dividend Yield
- ATEN 1.36%
- CDNA N/A
- EPS Growth
- ATEN 21.29
- CDNA N/A
- EPS
- ATEN 0.69
- CDNA 1.00
- Revenue
- ATEN $276,445,000.00
- CDNA $340,826,000.00
- Revenue This Year
- ATEN $10.47
- CDNA $13.02
- Revenue Next Year
- ATEN $7.38
- CDNA $12.85
- P/E Ratio
- ATEN $25.57
- CDNA $13.99
- Revenue Growth
- ATEN 11.04
- CDNA 14.72
- 52 Week Low
- ATEN $13.03
- CDNA $10.96
- 52 Week High
- ATEN $21.90
- CDNA $32.97
- Technical
- Relative Strength Index (RSI)
- ATEN 50.54
- CDNA 56.93
- Support Level
- ATEN $17.37
- CDNA $13.23
- Resistance Level
- ATEN $17.95
- CDNA $13.80
- Average True Range (ATR)
- ATEN 0.39
- CDNA 0.69
- MACD
- ATEN 0.06
- CDNA 0.17
- Stochastic Oscillator
- ATEN 59.57
- CDNA 90.16
About ATEN A10 Networks Inc.
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.